Citation Tools

Download PDFPDF

321 Preclinical potency assessment of SynKIR-110, a mesothelin-specific KIR-CAR T cell therapy for mesothelioma

Download to a citation manager

Cite this article as:
Xu J, Nunez-Cruz S, Rivera J, et al
321 Preclinical potency assessment of SynKIR-110, a mesothelin-specific KIR-CAR T cell therapy for mesothelioma